To this aim, by making use of ex vivo and in silico analysis, we have evaluated the expression levels of TSPAN32 in memory T cells from healthy donors and MS patients, both in inactive state and upon activation. This evidence concerns the gene TSPAN32 and myeloid sarcoma.